Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2026 Earnings Call Transcript May 5, 2026
Rhythm Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.83, expectations were $-0.86.
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Rhythm Pharmaceuticals First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to turn the conference over to Dave Connolly.
David...
